SeraCare to Sell RayBiotech Arrays, Kits | GenomeWeb
NEW YORK (GenomeWeb News) — SeraCare Life Sciences will sell RayBiotech’s full line of arrays and kits through its global network, SeraCare said today.
 
Under the agreement, SeraCare will serve as an agent in selling RayBiotech’s antibody arrays, protein arrays, tissue microarrays, and ELISA and EIA kits.
 
RayBiotech’s arrays target cytokines, chemokines, growth/angiogenic factors, adipokines, soluble receptors, matrix metalloproteases, and their inhibitors.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.